Background
==========

Polycystic kidney diseases (PKD) are a group of monogenic disorders characterized by cyst development in the kidney, but also often have extrarenal manifestations \[[@B1]\]. This group of disorders has been linked to defects in the functioning of primary cilia and therefore are termed ciliopathies \[[@B2]\]. The most common form of the disease (incidence 1/500-1000) is autosomal dominant PKD (ADPKD) that is typically a late onset disease characterized by progressive cyst development and often resulting in end-stage renal disease (ESRD) \[[@B3]\]. Clinically significant extrarenal manifestations include severe polycystic liver disease and an increased prevalence of intracranial aneurysms. ADPKD is genetically heterogeneous with two genes known, *PKD1* and *PKD2*\[[@B4],[@B5]\]. PKD1 accounts for \~85% of clinical cases and is associated with more severe disease, with ESRD at 54.3 y compared to 74 y for PKD2 \[[@B6]\]. Recent data from Cornec-Le Gall also indicated a significance difference in age at ESRD between PKD1 cases with truncating compared to non-truncating mutations (55.6 y vs. 67.9 y, respectively) \[[@B7]\]. Diagnostics is usually possible by renal imaging with specific criteria determined for a positive diagnosis by ultrasound \[[@B8],[@B9]\], but molecular diagnostic screens can also be helpful to determine the gene involved and to identify at-risk individuals \[[@B10],[@B11]\]. In particular, knowing the gene and mutation type can be of prognostic value (see above), and in rare cases where there is interest, facilitate preimplantation genetic diagnostics.

The most common recessive form of PKD, autosomal recessive PKD (ARPKD; incidence 1:20,000), is most often a neonatal onset disorder and associated with significant neonatal demise; although adult presentation of the disease associated with at least one hypomorphic allele is increasingly recognized \[[@B1],[@B12],[@B13]\]. A number of other recessively inherited, syndromic forms of PKD have additional disease manifestations likely associated with ciliary dysfunction \[[@B2]\]. These diseases include the lethal Meckel syndrome, Joubert syndrome, Bardet Biedl syndrome and orofacial digital syndrome. Extrarenal manifestations range from liver, eye and digital defects to central nervous system abnormalities, including mental retardation. These rare disorders are enriched in consanguineous populations.

We describe here a complex Iranian family with multiple consanguineous relationships that manifests PKD, but also a number of other abnormalities, including heart defects, renal agenesis and mental retardation. Molecular testing of the ADPKD genes identified the molecular defect; highlighted variability associated with this mutation, and diagnosed at-risk individuals with negative or equivocal renal imaging data.

Patients and methods
====================

The study was approved by the Ethics Committee at the Islamic Azad University (8888117001) and the Mayo Clinic IRB (285--00). Written informed consent was obtained from all patients for publication of this Case report. A copy of the written consent is available for review by the Editor of this journal. Clinical information was obtained by review of the clinical records and by interviewing the patients. Clinical data on kidney function (serum creatinine) and ultrasound imaging data to determine kidney size, number of cysts and the presence of renal stones was obtained for at-risk individuals, as available. The pedigree was drawn employing the Cyrillic program. Blood samples were collected from 25 family members for DNA isolation by standard salting out methods. The genomic DNA of the proband (V:16) was PCR amplified for all the coding exons of the *PKD1* and *PKD2* genes following previously published protocols \[[@B14]-[@B16]\]. Mutation analysis was performed by bidirectional sequencing on PCR-amplified products of all the coding exons for both the *PKD1* and the *PKD2* gene. Chromatograms were analyzed using the software Mutation Surveyor (SoftGenetics Inc.). Segregation analysis for the detected disease-associated mutation was performed in all available family members.

Case presentation
=================

This family first came to our notice when the proband (V:16) underwent abdominal ultrasound analysis at 30 y and a single, large cyst was detected in each kidney. Although these results did not meet the Ravine criteria for an ADPKD diagnosis, taking a family history revealed evidence of other family members with renal cystic disease (Table [1](#T1){ref-type="table"}). Careful tracing of the family, plus renal ultrasound analysis and serum creatinine measurements, revealed a large family in which 125 individuals could be traced with at least 30 having some evidence of renal cystic disease, in four generations (Figure [1](#F1){ref-type="fig"}). The family had at least nine consanguineous couples, usually first cousins, and also cases with mental retardation, congenital heart disease renal agenesis and early onset ESRD. Although the consanguinity and range of extra-renal manifestations (some similar to those found in ciliopathies) suggested that recessive inheritance may be important, the PKD seemed to be inherited mainly in a dominant fashion. We, therefore, screened the ADPKD genes, *PKD1* and *PKD2,* by sequence analysis for mutations in the proband. This screening revealed a *PKD2* deletion, c.1142delG: p.G381fs71X as the only likely disease causing mutation (Figure [2](#F2){ref-type="fig"}). Segregation analysis in the subjects where DNA was available showed that 16 had the *PKD2* mutation indicating that this is a PKD2 family. PKD2 is typically a much milder disease than PKD1 and this is reflected in this family where many individuals had rather few cysts and normal renal function (Table [1](#T1){ref-type="table"}). Exceptions were IV:20 who had a renal transplant at 50 y and V:1 who started dialysis at 54 y. Other individuals with marked renal insufficiency were V:29 with an eGFR of 20 ml/min/1.73 m^2^ at 54 y, V:39 with an eGFR of 31 ml/min/1.73 m^2^ at 38 years and two older family members with eGFR of 27 (IV:10) and 39 ml/min/1.73 m^2^ (IV:17) at 75 y and 63 y, respectively. Several younger individuals shown to inherit the *PKD2* mutation had cyst numbers below the threshold for diagnosis by ultrasound and in at least one case at 20y (VI:30) no renal or hepatic cysts were detected. Kidney stones were commonly found in affected cases and are a known complication of ADPKD.

![**Pedigree of the large Iranian family showing the PKD (Affected) and other phenotypes found in the family (see key for details).** The genotype for the *PKD2*: 1142delG mutation is indicated as N=normal or, d=deleted.](1471-2369-14-190-1){#F1}

![**Sequence chromatograph showing the deletion of G at position 1142 in exon 5 of the*PKD2*gene.** Note that the G is in a run of four Gs that may have contributed to this frame-shifting mutation at this site.](1471-2369-14-190-2){#F2}

###### 

Clinical details of affected cases and others with unusual phenotypes

             **Patient No.**             **Sex**   **Age (y)+**   **Renal Function (Serum Creatinine; mg/dl)**   **Kidney Length\^ (mm)**   **Notable Kidney Features from Imaging\***       **Other Findings**            **Genetic results**                                                       
  ------------------------------------- --------- -------------- ---------------------------------------------- -------------------------- -------------------------------------------- ----------------------------- ------------------------------ ----------------------------------------------- ----------
              **Affected**                                                                                                                                                                                                                                                                                
                  III:4                     F           56                            N/A                                  N/A                                 N/A                                   N/A                           N/A                                  Dead; PKD                       N/D
                  III:8                     M           63                            N/A                                  N/A                                 N/A                                   N/A                           N/A                                  Dead; PKD                       N/D
                  IV:9                      F           67                            1.4                                  113                                 125                               LC 10x6 mm                       Normal                                                              1142delG
                  IV:10                     F           75                            1.8                                  108                                 135                             Multiple cysts                   9 mm stone                                                            1142delG
                  IV:13                     M           77                      Dialysis (75 y)                            105                                 100                               LC 22x10 mm           11 mm stone in middle caulis                     Dead; PKD                       N/D
                  IV:17                     M           63                            1.8                                  118                                 110                               LC 15x8 mm                     9 mm stone                                                            1142delG
                  IV:20                     F           53                         Tx (50 y)                               150                                 160                             Multiple cysts                 Multiple cysts                            Dead; PKD                       N/D
                  IV:23                     M           50                            0.9                                  115                                 105                               4 mm stone                     LC 15x8 mm                                                              N/D
                   V:1                      M           54                      Dialysis (54 y)                            N/A                                 N/A                                   N/A                           N/A                                  Dead; PKD                       N/D
                   V:5                      M           42                            1.1                                  125                                 110                               LC 15x8 mm                     3 mm stone                                                            1142delG
       2 mm stone in middle caulis                                                                                                                                                                                                                                                                   
                   V:9                      F           38                            1.3                                  100                                  95                               LC 23x18 mm           9 mm stone in middle caulis                                                    1142delG
      3.5 mm stone in middle caulis                                                                                                                                                                                                                                                                  
                  V:14                      M           32                            0.9                                  105                                 105                             Multiple cysts                   Stone 3 mm                                                            1142delG
             V:16 (proband)                 M           30                            1.2                                  105                                 100                            1 cyst, 12x12 mm               1 cyst, 27x22 mm                                                         1142delG
                  V:22                      M           46                            1.2                                  118                                 110                               3 mm stone                  1 cyst, 13x13 mm                                                         1142delG
                  V:24                      M           35                            0.9                                  105                                 107                                 Normal                       2 mm stone                                                            1142delG
                  V:27                      F           49                            1.3                                  108                                 115                                 Normal                      3.5 mm stone                                                           1142delG
                LC 3x3 mm                                                                                                                                                                                                                                                                            
                  V:29                      F           54                            2.5                                  105                                 110                             1 cyst 10x10 mm                1 cyst, 8x8 mm                          1 liver cyst                    1142delG
               3 mm stone                                                                                                                                                                                                                                                                            
                  V:39                      F           38                            1.8                                  160                                 170                             Multiple cysts                 Multiple cysts                                                          1142delG
   4.5 mm stone in interlobular region                                                                                                                                                                                                                                                               
                  V:43                      F           37                            0.7                                  112                                 124                                 Normal                    1 cyst, 13x13 mm                      22x23 mm liver cyst                1142delG
                  VI:5                      F           20                            0.7                                   95                                  90                              1.5 mm stone                      Normal                                                              1142delG
                  VI:6                      F           16                            0.7                                  108                                 109                                 Normal                       3 mm stone                                                            1142delG
                  VI:30                     F           16                            0.8                                  108                                  98                                 Normal                         Normal                                                              1142delG
    **PKD suspected but not proven**                                                                                                                                                                                                                                                                      
                  IV:15                     M           62                            0.8                                  105                                 100                               LC 20x10 mm           9 mm stone in middle caulis                                                      N/D
      3.5 mm stone in middle caulis                                                                                                                                                                                                                                                                  
                  IV:19                     F           51                            1.5                                  108                                 105                       1 cyst, 12x8 mm;10 mm stone   11 mm stone in middle caulis                                                     N/D
                  V:10                      F           41                            1.2                                  108                                 105                             1 cyst, 10x5 mm                    Normal                                                                N/D
                  V:19                      M           40                            1.1                                  112                                 108                             1 cyst, 6x6 mm                     Normal                                                                N/D
                  V:25                      M           32                            0.8                                  100                                 105                             1 cyst, 6x6 mm                     Normal                                                                N/D
                  V:26                      M           26                            0.8                                  105                                 100                               2 mm stone                     1 mm stone                                                              N/D
                  VI:2                      F           14                            0.8                                   95                                 107                                 Normal              1 cyst, 5x4 mm; 1.5 mm stone                                                     N/D
                  VI:14                     M           24                            1.3                                  107                                 105                               2 mm stone                   1 cyst, 7x6 mm                                                            N/D
                  VI:16                     M           24                            1.7                                  110                                 112                                 Normal                    1 cyst, 8X10 mm                                                            N/D
                  VI:17                     F           17                            0.8                                   95                                  95                                 1 stone                        Normal                                                                N/D
                  VI:22                     M           45                            1.4                                  107                                 105                              1 cyst, 8x5mm                  2.6 mm stone                                                             N/D
                  VI:24                     M           33                            1.1                                  112                                 100                              1 cyst, 6 mm                      Normal                                                                N/D
             **Unaffected**                                                                                                                                                                                                                                                                               
                   V:3                      F           53                            0.9                                  105                                \-\--                                Normal                  Congenitally absent                                                         1142G
                  V:17                      M           39                            0.9                                  110                                 100                                 Normal                         Normal                                                                N/D
                  V:32                      F           64                            3.59                                 100                                  95                       43 mm stone, hydronephrosis           6.7 mm stone                                                            1142G
                  VI:9                      F           20                            0.7                                  100                                  96                                 Normal                         Normal                    Non Syndromic Mental Retardation,           N/D
            Normal Karyotype                                                                                                                                                                                                                                                                         
                  VI:10                     M           16                            0.7                                  108                                 109                                 Normal                         Normal                    Non Syndromic Mental Retardation            N/D
            Normal Karyotype                                                                                                                                                                                                                                                                         
                  VI:19                     F           34                            0.8                                   95                                 105                                 Normal                         Normal                                                               1142G
                  VI:20                     M           46                            0.7                                  100                                 105                                 Normal                         Normal                                                               1142G
                  VI:28                     M           ?                             N/A                                  N/A                                 N/A                                   N/A                           N/A                Congenital heart disease, Down syndrome; Dead     N/D
                  VII:3                     M           17                          Tx (14y)                                85                                \-\--                               No cysts                 Congenitally absent                     Reflux Nephropathy                  1142G

\**LC*, largest cyst; \^*N/E*, not enlarged; *N/D*, not determined; *N/A*, not available; + = age last imaging data available.

A risk in such a consanguineous family is that both parents will be affected in which case one in four of their pregnancies would be homozygous for the *PKD2* mutation. *Pkd2*^*−/−*^ mice are embryonic lethal, dying by 14.5d of gestation, and it is assumed in humans, but never proven, that having two fully penetrant *PKD2* mutations is incompatible with life. To further determine the significance of the *PKD2* mutation in this family, we analyzed a number of family members with unusual manifestations, including kidney agenesis, early onset ESRD or other extra-renal manifestations sometimes related with syndromic PKD, to see if the *PKD2* mutant allele could be playing a role. IV:17 is affected and second cousin to his partner (V:3), who had just a single kidney, but genetic analysis showed she did not have the *PKD2* mutation. V:40 is married to his affected first cousin (V:39) and they had two children who died at a young age (one with Down syndrome and congenital heart disease), but again the father did not have the *PKD2* mutation. VII:3 had a solitary kidney and ESRD requiring a renal transplant at 14y, although no cysts were detected. His maternal grandmother (V:29) had renal insufficiency due to PKD (Table [1](#T1){ref-type="table"}) and large kidney stones and the paternal grandmother (V:32) had kidney stones and hydronephrosis. However, genetic analysis showed that neither of his parents (VI:19 nor VI:20) or the paternal grandmother had the *PKD2* mutation, and so the renal failure was not PKD related and most likely due to reflux nephropathy. The two sibs with mental retardation (VI:9 and VI:10) are at risk for PKD2 as the father is affected, but neither had evidence of cysts at 20y and 16y, respectively. Unfortunately, no samples were available to test if they had the *PKD2* mutation.

Conclusions
===========

We describe here an Iranian family with multiple consanguinity loops with over 30 individuals with PKD. Despite the complex structure of the family, by molecular testing we have been able to show that the PKD is due to a truncating mutation to *PKD2*. This firm diagnosis rules out that syndromic forms of PKD that are enriched in consanguineous populations are playing a role and showed that renal failure in one child was not related to the *PKD2* mutation.

Considerable phenotypic variability was seen in the family both in terms of renal survival, kidney dimensions and the occurrence of kidney stones. However, it is well document that there can be considerable intra-familial variability in ADPKD, indicating that other genetic and environmental factors significantly influence the phenotype \[[@B17]\].

Renal ultrasound and other imaging methods are a reasonably reliable method to diagnose ADPKD in at-risk adults. However, ultrasound is less reliable in the milder PKD2, especially in younger individuals, as illustrated in this family with several cases with equivocal imaging data, showing even with the recent ultrasound criteria that there is a significant false negative rate, especially when state-of-the-art ultrasound equipment is not employed \[[@B8],[@B18]\]. Molecular diagnostics in ADPKD requires some considerable effort because of the involvement of the large and complex *PKD1* gene, as well as *PKD2*, and because of the high level of allelic heterogeneity meaning that both genes need to be fully sequenced to identify the disease gene \[[@B10],[@B19]\]. Commercial testing is therefore expensive. However, this family illustrates the useful role for molecular diagnostics in ADPKD. PKD2 was identified as the disease, and once the disease mutation has been detected the rest of the family can be readily and inexpensively screened, with unequivocal diagnostic data obtained. In this family, this has helped resolve the etiology in some patients with unusual phenotypes and identified those at risk for developing ADPKD even if no clinical signs are yet present. This means precious resources can be concentrated on following these individuals, with prompt treatment of hypertension, urinary tract infections, kidney stones and other complications \[[@B11]\]; and not those unaffected. Although molecular diagnostic is not required in every suspected ADPKD family it does have a valuable part to play in some complex families.
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